15 Frequently Asked Questions : Leukemia, Lymphoma and Blood Cancer Treatments in India for Uzbek Patients

Q1 · What are Leukemia, Lymphoma and Blood Cancer Treatments?

Blood cancer treatment is a broad term covering different medical treatments used for cancers affecting blood-forming cells, bone marrow, lymphocytes and the lymphatic system.

Leukemia

Leukemia is a cancer of blood-forming tissues in which abnormal blood cells accumulate in the bone marrow and blood.

Major types include

• Acute lymphoblastic leukemia (ALL)
• Acute myeloid leukemia (AML)
• Chronic lymphocytic leukemia (CLL)
• Chronic myeloid leukemia (CML)

Some leukemias progress rapidly, while others may develop more slowly.

Lymphoma

Lymphoma begins in lymphocytes, which are immune-system cells.

The two major categories are

• Hodgkin lymphoma
• Non-Hodgkin lymphoma

Non-Hodgkin lymphoma includes many different subtypes, including both slower-growing and aggressive forms.

Treatment Approaches

Depending on the disease, treatment may involve

• Chemotherapy
• Targeted therapy
• Immunotherapy
• Radiation therapy
• Stem cell transplantation
• Bone marrow transplantation
• CAR-T cell therapy in selected patients
• Supportive treatment
• Blood and platelet transfusions
• Infection management

The treatment is selected according to the exact blood cancer rather than using the same treatment for every patient.

Q2 · How much do Leukemia, Lymphoma and Blood Cancer Treatments cost in Uzbekistan compared with India?

Costs vary substantially because blood cancer treatment may involve several cycles of chemotherapy, targeted medicines, immunotherapy, hospitalisation, transplantation or cellular therapy.

For indicative planning, this guide uses

• US$1 ≈ UZS 12,200
• US$1 ≈ INR 96

These figures are planning estimates and may change substantially depending on the disease and treatment protocol.

The final quotation may depend on

• Diagnosis
• Molecular testing
• Number of treatment cycles
• Medicines selected
• Targeted or immunotherapy requirements
• Hospitalisation
• ICU requirements
• Blood and platelet transfusions
• Infection treatment
• Stem-cell collection
• Donor matching
• Transplant procedure
• Cellular therapy
• Follow-up investigations

Patients should request a detailed written quotation before travelling.

Q3 · Which Indian cities can Uzbek patients consider for Leukemia, Lymphoma and Blood Cancer Treatments?

Patients requiring stem-cell transplantation or cellular therapy should specifically confirm that the selected centre has an active programme appropriate for their disease.

Q4 · Which hospitals in India can Uzbek patients consider for Leukemia, Lymphoma and Blood Cancer Treatments?

Not every hospital listed provides every blood cancer treatment or transplantation service. Uzbek patients should specifically confirm the availability of the required hematology team, transplant programme, cellular therapy programme, blood-bank support and intensive-care facilities before travelling.

Q5 · What types of Leukemia, Lymphoma and Blood Cancer Treatments are available?

1. Chemotherapy

Chemotherapy uses medicines to destroy cancer cells or stop their growth. It remains an important treatment for many leukemias and lymphomas.

2. Targeted Therapy

Targeted medicines act against specific molecular or cellular features of the cancer.

Some leukemias and lymphomas have specific genetic or molecular abnormalities that can guide targeted treatment.

3. Immunotherapy

Immunotherapy uses the patient's immune system or immune-based medicines to attack cancer cells.

4. Monoclonal Antibody Therapy

Some lymphomas are treated with antibodies directed against specific proteins on cancer cells.

5. Radiation Therapy

Radiation may be used for selected lymphomas, localised disease, symptom control or certain situations involving the central nervous system.

6. Stem Cell Transplantation

Stem-cell transplantation may be considered for selected leukemias, lymphomas and other blood cancers.

It may be

• Autologous
• Allogeneic

7. Bone Marrow Transplantation

Bone marrow transplantation is a form of stem-cell transplantation in which blood-forming stem cells are used to restore the bone marrow after intensive treatment.

8. CAR-T Cell Therapy

CAR-T treatment involves collecting certain immune cells, modifying them in a specialised laboratory and returning them to the patient so they can recognise and attack cancer cells.

It is used for selected blood cancers and is not appropriate for every patient.

9. Supportive Treatment

Supportive care may include

• Blood transfusions
• Platelet transfusions
• Antibiotics
• Antiviral treatment
• Antifungal treatment
• Nutritional support
• Management of treatment-related complications

10. Maintenance Treatment

Some blood cancers require longer-term maintenance treatment after the initial treatment phase.

Q6 · Who may be suitable for Leukemia, Lymphoma and Blood Cancer Treatments?

Suitability depends on the exact blood cancer.

Doctors may consider

• Cancer type
• Cancer subtype
• Disease stage
• Molecular findings
• Cytogenetic findings
• Age
• General health
• Kidney function
• Liver function
• Heart and lung function
• Previous treatment
• Response to treatment
• Relapse status
• Donor availability where transplantation is being considered

Leukemia

Acute leukemia often requires rapid specialist treatment.

Chronic leukemias may have different treatment strategies, and some patients may initially be monitored depending on their disease.

Lymphoma

Treatment depends on whether the lymphoma is

• Hodgkin lymphoma
• Non-Hodgkin lymphoma
• Indolent
• Aggressive
• Newly diagnosed
• Relapsed
• Refractory

Transplantation

Stem-cell transplantation may be considered when the potential benefits outweigh the significant risks and the patient is medically suitable.

CAR-T Therapy

CAR-T treatment is reserved for selected patients who meet disease-specific and clinical eligibility criteria.

Q7 · What tests are required before Leukemia, Lymphoma and Blood Cancer Treatment?

The exact testing depends on the diagnosis.

Patients may require

• Complete blood count
• Peripheral blood smear
• Bone-marrow aspiration
• Bone-marrow biopsy
• Flow cytometry
• Cytogenetic testing
• Molecular genetic testing
• Immunohistochemistry
• Lymph-node biopsy
• PET-CT
• CT scan
• MRI where appropriate
• Lumbar puncture where clinically indicated
• Liver-function tests
• Kidney-function tests
• Electrolytes
• Viral screening
• ECG
• Echocardiogram
• Pulmonary assessment where required

For leukemia, bone-marrow and molecular testing can be particularly important for classification and treatment planning. For lymphoma, biopsy and appropriate staging imaging are important in determining the specific lymphoma subtype and extent of disease.

Before transplantation, additional tests may be required to assess

• Heart function
• Lung function
• Kidney function
• Liver function
• Infection status
• Donor compatibility

Q8 · What medical records should Uzbek patients send before travelling?

Patients should provide as many of the following records as possible

• Complete blood-count reports
• Peripheral blood smear
• Bone-marrow aspiration report
• Bone-marrow biopsy report
• Flow-cytometry report
• Cytogenetic report
• Molecular genetic reports
• Immunohistochemistry
• Lymph-node biopsy report
• PET-CT report
• CT/MRI reports
• Previous pathology reports
• Previous chemotherapy records
• Previous radiation records
• Previous transplant records
• Previous treatment response reports
• Current medication list
• Blood-transfusion history
• Infection history
• Discharge summaries

Patients should also clearly state

• Exact diagnosis
• Date of diagnosis
• Current disease status
• Whether the disease is newly diagnosed or recurrent
• Previous treatment
• Number of chemotherapy cycles completed
• Response to previous treatment
• Current blood counts
• Any known genetic or molecular abnormalities
• Whether transplantation has been recommended

Whenever possible, patients should share the original imaging and pathology documents rather than only a brief summary.

Q9 · How does Leukemia, Lymphoma and Blood Cancer Treatment work?

The treatment pathway varies by disease.

Step 1: Confirm the Diagnosis

The hematology team confirms the exact blood cancer subtype using pathology, blood tests, bone-marrow studies, flow cytometry and molecular testing where required.

Step 2: Stage or Classify the Disease

The team determines the extent and biological characteristics of the disease.

Step 3: Assess the Patient

The team evaluates

• General health
• Organ function
• Infection risk
• Previous treatment
• Ability to tolerate intensive therapy

Step 4: Select Treatment

Treatment may include

• Chemotherapy
• Targeted therapy
• Immunotherapy
• Radiation
• Stem-cell transplantation
• Cellular therapy

Step 5: Monitor Treatment Response

Monitoring may include

• Blood counts
• Bone-marrow examinations
• Imaging
• Molecular testing
• Minimal residual disease testing where appropriate

Step 6: Consolidation or Maintenance

Some blood cancers require additional treatment after the initial response to reduce the risk of recurrence.

Step 7: Transplantation Where Appropriate

Selected patients may proceed to autologous or allogeneic stem-cell transplantation.

Step 8: Long-Term Follow-Up

Follow-up may monitor

• Disease recurrence
• Treatment complications
• Infections
• Blood counts
• Organ function
• Nutritional status
• Late effects

Q10 · What are the alternatives to Leukemia, Lymphoma and Blood Cancer Treatments?

Depending on the exact diagnosis, alternatives or additional approaches may include

• Active surveillance
• Chemotherapy
• Targeted therapy
• Immunotherapy
• Radiation therapy
• Stem-cell transplantation
• CAR-T cell therapy
• Clinical trials
• Supportive care
• Palliative treatment

Active Surveillance

Some slower-growing blood cancers may be monitored without immediate treatment when there are no indications requiring active therapy.

Chemotherapy

Chemotherapy remains an important treatment for many leukemias and lymphomas.

Targeted Therapy

Targeted treatment may be used when the cancer has a molecular feature that can be treated with a specific medicine.

Immunotherapy

Immunotherapy may be used for selected blood cancers.

Stem-Cell Transplantation

Transplantation can be considered for selected patients, particularly where intensive treatment followed by replacement of blood-forming stem cells is appropriate.

CAR-T Cell Therapy

Selected relapsed or treatment-resistant blood cancers may qualify for CAR-T therapy.

Supportive and Palliative Care

Supportive care can be provided alongside cancer treatment or when the primary goal becomes symptom control and quality of life.

Q11 · What should Uzbek patients ask before accepting a Leukemia, Lymphoma or Blood Cancer Treatment quotation?

Patients should ask

• What is the exact blood cancer diagnosis?
• What is the exact subtype?
• What is the stage or disease classification?
• Are molecular tests available?
• Are cytogenetic tests available?
• Is bone-marrow testing required?
• Is the disease newly diagnosed or recurrent?
• What treatment is recommended?
• What is the goal of treatment?
• How many chemotherapy cycles may be required?
• Which targeted medicines may be required?
• Is immunotherapy required?
• Is radiation therapy required?
• Is stem-cell transplantation recommended?
• Is the patient eligible for autologous transplantation?
• Is allogeneic transplantation being considered?
• Is a suitable donor available?
• Is CAR-T therapy appropriate?
• What supportive medicines are required?
• Could ICU treatment be required?
• How long is each hospital stay?
• How long will the overall treatment take?
• What complications are possible?
• What infection precautions are required?
• Are blood and platelet transfusions included?
• Are medicines included in the quotation?
• Are laboratory investigations included?
• Are bone-marrow examinations included?
• Are transplant-related tests included?
• What costs could arise outside the initial quotation?
• How will treatment response be monitored?
• What happens if the disease does not respond?
• What follow-up is required after returning to Uzbekistan?
• Can further treatment be continued in Uzbekistan?
• What medical records will be provided at discharge?

Patients should request a detailed written quotation and treatment schedule before travelling.

Q12 · How long should Uzbek patients stay in India for Leukemia, Lymphoma and Blood Cancer Treatment?

The duration varies significantly according to the diagnosis and treatment.

For diagnostic evaluation and treatment planning, the patient may initially require several days to complete

• Specialist consultations
• Blood testing
• Pathology review
• Imaging
• Bone-marrow testing
• Molecular testing

Chemotherapy may involve repeated hospital visits or admissions over several weeks or months.

For stem-cell transplantation, the patient generally needs a substantially longer period in India because of

• Pre-transplant evaluation
• Conditioning treatment
• Stem-cell infusion
• Blood-count monitoring
• Infection monitoring
• Management of complications
• Early post-transplant recovery

For complex transplant treatment, Uzbek patients may need to plan for several weeks to several months, depending on the type of transplant and recovery. CAR-T treatment can also require an extended treatment journey because of cell collection, laboratory processing, preparatory treatment, infusion and close monitoring. Patients should not arrange a fixed return date until the treating team confirms the medical timeline.

Q13 · What is recovery like after Leukemia, Lymphoma and Blood Cancer Treatment?

Recovery depends heavily on the treatment.

During intensive chemotherapy or transplantation, patients may experience

• Fatigue
• Low blood counts
• Reduced immunity
• Fever
• Nausea
• Reduced appetite
• Mouth ulcers
• Hair loss
• Weakness
• Increased infection risk

After transplantation, patients may require prolonged monitoring for complications such as infections and other transplant-related effects.

Recovery may require

• Regular blood tests
• Blood or platelet transfusions
• Antibiotic or antiviral treatment
• Nutritional support
• Careful infection prevention
• Medication management
• Gradual physical activity

Seek urgent medical attention for:

• Fever
• Chills
• Severe weakness
• Difficulty breathing
• Persistent vomiting
• Uncontrolled bleeding
• Severe diarrhoea
• Confusion
• New neurological symptoms
• Severe abdominal pain
• Any sudden deterioration

Patients receiving intensive cancer treatment should follow the treating team's infection-prevention and emergency instructions carefully.

Q14 · How can follow-up be managed after returning to Uzbekistan?

Before leaving India, patients should obtain

• Final diagnosis
• Complete treatment summary
• Pathology reports
• Bone-marrow reports
• Molecular and cytogenetic reports
• Imaging reports
• Chemotherapy protocol
• Medication list
• Transplant report where applicable
• Stem-cell information where applicable
• CAR-T treatment documentation where applicable
• Blood-count results
• Follow-up schedule

Follow-up may include

• Complete blood counts
• Bone-marrow examination
• Molecular testing
• Minimal residual disease testing where appropriate
• PET-CT or CT where required
• Medication monitoring
• Infection monitoring

For transplant patients, follow-up may also involve monitoring for

• Infection
• Graft-versus-host disease after allogeneic transplantation
• Organ complications
• Blood-count recovery
• Nutritional problems
• Long-term treatment effects

If treatment needs to continue in Uzbekistan, the Indian hematology team should provide a clear written protocol that can be shared with the local treating team.

Q15 · Should an Uzbek patient travel to India for Leukemia, Lymphoma and Blood Cancer Treatment?

Uzbek patients considering treatment in India should first have their complete diagnosis and treatment history reviewed by an appropriate hematology or hemato-oncology team.

Before travelling, patients should understand

• Exact blood cancer type
• Exact subtype
• Stage or disease classification
• Molecular findings
• Cytogenetic findings
• Current disease status
• Previous treatment
• Treatment response
• Proposed treatment
• Expected number of treatment cycles
• Need for targeted therapy
• Need for immunotherapy
• Need for radiation
• Need for transplantation
• Eligibility for CAR-T or other cellular treatment where relevant
• Expected hospitalisation
• Expected overall duration in India
• Estimated treatment cost
• Possible complications
• Follow-up requirements

Blood cancers can require urgent and highly specialised treatment. Patients should therefore avoid delaying necessary medical care while arranging international travel. A detailed written treatment plan and cost estimate should be obtained before travel, with the understanding that the final treatment may change after complete diagnostic review.